The highest FDA-approved dose of pravastatin is 80 mg per day, but even that doesn’t qualify as “high-intensity” statin therapy by current medical standards. Pravastatin tops out at moderate intensity, meaning it can lower LDL cholesterol by 30% to just under 50%, but it can’t match the 50%-plus reductions that stronger statins achieve. Understanding where pravastatin sits on this spectrum matters because it affects whether your prescription is likely to hit your cholesterol target.
How Pravastatin Doses Are Classified
The American College of Cardiology and American Heart Association group all statin doses into three intensity tiers based on how much they lower LDL cholesterol. For pravastatin, the breakdown looks like this:
- Low intensity (10 to 20 mg): reduces LDL by less than 30%
- Moderate intensity (40 to 80 mg): reduces LDL by 30% to just under 50%
- High intensity: not available with pravastatin at any dose
So when your doctor prescribes pravastatin 80 mg, you’re taking the maximum approved dose of the drug, but you’re still receiving moderate-intensity therapy. Only two statins currently reach the high-intensity category: atorvastatin at 40 to 80 mg and rosuvastatin at 20 to 40 mg. This distinction is important if you’ve had a heart attack or stroke, since guidelines typically recommend high-intensity therapy in those situations, and pravastatin alone wouldn’t meet that threshold.
What Each Dose Actually Does to LDL
The LDL reductions at each pravastatin dose are well established. At 20 mg, expect roughly a 27% drop. At 40 mg, around 34%. At the maximum 80 mg, about 41%. Notice that doubling the dose from 40 to 80 mg only gains you about 7 extra percentage points of LDL reduction. This diminishing return is typical of all statins and is one reason the FDA label recommends starting most adults at 40 mg and reserving the 80 mg dose for people who don’t reach their LDL goal on 40 mg.
For comparison, atorvastatin 10 mg (its lowest dose) produces a similar LDL reduction to pravastatin 80 mg. That gap in potency is why clinicians sometimes switch patients to a different statin rather than pushing pravastatin to its ceiling.
When the Maximum Dose Gets Capped Even Lower
Certain medications interact with pravastatin in ways that raise the risk of muscle damage, so the safe upper limit drops depending on what else you’re taking. If you take cyclosporine (an immune-suppressing drug common after organ transplants), the maximum is generally 20 mg per day, starting at just 10 mg. If you take clarithromycin, a widely used antibiotic, the cap is 40 mg. And if you take niacin for cholesterol, your doctor may lower the pravastatin dose further because the combination increases the chance of muscle-related side effects.
These limits exist because the interacting drugs slow the body’s ability to clear pravastatin, effectively making a moderate dose behave like a much higher one in your system.
Side Effects at Higher Doses
Pravastatin is considered one of the better-tolerated statins, but side effect risk does climb with dose. A meta-analysis of nine controlled trials comparing low and high statin doses found that liver enzyme elevations (a marker doctors watch to ensure the liver isn’t under stress) occurred in about 1.5% of patients on high doses versus 0.4% on low doses. Pravastatin was specifically called out alongside atorvastatin as statins where this dose-dependent pattern was more pronounced.
That said, clinical trials testing pravastatin at 80 mg and even an experimental 160 mg dose found no cases of significant liver enzyme elevations over a six-week period, suggesting that serious liver injury at the 80 mg dose is rare. Muscle pain and weakness remain the more common concern, particularly when pravastatin is combined with the interacting drugs mentioned above.
Evidence Behind the 40 mg Dose
Most of the major clinical trials that established pravastatin’s cardiovascular benefits used 40 mg, not 80 mg. The PROSPER trial enrolled over 5,800 adults aged 70 to 82 who were at risk for heart disease and assigned them to either 40 mg of pravastatin daily or a placebo. After about 3.2 years, the group taking pravastatin had a 15% lower rate of the combined endpoint of heart attack, stroke, and death from coronary disease. The benefit was strongest for heart-related events specifically: a 19% reduction in heart attack or coronary death. Extended follow-up out to 8.6 years confirmed a lasting 20% reduction in fatal coronary events.
This means the dose most people take (40 mg) has solid evidence behind it, and the 80 mg dose is typically reserved for those who need additional LDL lowering but prefer to stay on pravastatin rather than switch to a more potent statin.
Doses for Children and Adolescents
Pravastatin is one of the few statins approved for use in children with inherited high cholesterol. Dosing is lower and age-dependent. In clinical studies, children aged 8 to 13 typically received 20 mg per day, while adolescents 14 and older were given up to 40 mg. The 80 mg dose has not been broadly studied or recommended in pediatric patients, so 40 mg represents the upper end for teenagers.